###begin article-title 0
Susceptibility of Pancreatic Beta Cells to Fatty Acids Is Regulated by LXR/PPARalpha-Dependent Stearoyl-Coenzyme A Desaturase
###end article-title 0
###begin p 1
###xml 95 98 <span type="species:ncbi:40640?0.2727272727272727">PVV</span>
###xml 133 136 <span type="species:ncbi:40640?0.2727272727272727">PVV</span>
###xml 193 196 <span type="species:ncbi:40640?0.2727272727272727">PVV</span>
Conceived and designed the experiments: KHH KRS. Performed the experiments: KHH JCH KRS CR EDV PVV. Analyzed the data: KHH BD KRS GM PVV. Contributed reagents/materials/analysis tools: KHH KRS PVV JG DP. Wrote the paper: KHH. Contributed to writing the paper: KRS GM JAG DP.
###end p 1
###begin p 2
###xml 1023 1026 1016 1019 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 1043 1046 1029 1032 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 149 152 <span type="species:ncbi:10116">Rat</span>
###xml 676 679 <span type="species:ncbi:10116">rat</span>
###xml 681 686 <span type="species:ncbi:10090">mouse</span>
###xml 691 696 <span type="species:ncbi:9606">human</span>
###xml 992 996 <span type="species:ncbi:10090">mice</span>
###xml 1235 1239 <span type="species:ncbi:10116">rats</span>
###xml 1247 1251 <span type="species:ncbi:10116">rats</span>
###xml 1377 1380 <span type="species:ncbi:10116">rat</span>
Chronically elevated levels of fatty acids-FA can cause beta cell death in vitro. Beta cells vary in their individual susceptibility to FA-toxicity. Rat beta cells were previously shown to better resist FA-toxicity in conditions that increased triglyceride formation or mitochondrial and peroxisomal FA-oxidation, possibly reducing cytoplasmic levels of toxic FA-moieties. We now show that stearoyl-CoA desaturase-SCD is involved in this cytoprotective mechanism through its ability to transfer saturated FA into monounsaturated FA that are incorporated in lipids. In purified beta cells, SCD expression was induced by LXR- and PPARalpha-agonists, which were found to protect rat, mouse and human beta cells against palmitate toxicity. When their SCD was inhibited or silenced, the agonist-induced protection was also suppressed. A correlation between beta cell-SCD expression and susceptibility to palmitate was also found in beta cell preparations isolated from different rodent models. In mice with LXR-deletion (LXRbeta-/- and LXRalphabeta-/-), beta cells presented a reduced SCD-expression as well as an increased susceptibility to palmitate-toxicity, which could not be counteracted by LXR or PPARalpha agonists. In Zucker fatty rats and in rats treated with the LXR-agonist TO1317, beta cells show an increased SCD-expression and lower palmitate-toxicity. In the normal rat beta cell population, the subpopulation with lower metabolic responsiveness to glucose exhibits a lower SCD1 expression and a higher susceptibility to palmitate toxicity. These data demonstrate that the beta cell susceptibility to saturated fatty acids can be reduced by stearoyl-coA desaturase, which upon stimulation by LXR and PPARalpha agonists favors their desaturation and subsequent incorporation in neutral lipids.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 292 295 292 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Donath1">[1]</xref>
###xml 296 299 296 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Cnop1">[4]</xref>
###xml 407 410 407 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Prentki1">[5]</xref>
###xml 679 682 679 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Cnop2">[6]</xref>
###xml 684 687 684 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Hellemans1">[7]</xref>
###xml 871 874 871 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Martens1">[8]</xref>
###xml 875 879 875 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Kiekens1">[10]</xref>
###xml 1013 1016 1013 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Cnop2">[6]</xref>
###xml 1167 1170 1167 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Cnop2">[6]</xref>
###xml 1172 1176 1172 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Borg1">[11]</xref>
###xml 1303 1307 1303 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Maedler1">[12]</xref>
###xml 1308 1312 1308 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Diakogiannaki1">[14]</xref>
###xml 1410 1414 1410 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Sol1">[15]</xref>
###xml 1416 1420 1416 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-AssimacopoulosJeannet1">[16]</xref>
###xml 1617 1620 1610 1613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Hellemans1">[7]</xref>
###xml 1870 1874 1859 1863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Flowers1">[17]</xref>
###xml 1876 1880 1865 1869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Listenberger1">[18]</xref>
###xml 1989 1993 1978 1982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Pinnamaneni1">[19]</xref>
###xml 2120 2124 2109 2113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Pinnamaneni1">[19]</xref>
###xml 2125 2129 2114 2118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Peter1">[21]</xref>
###xml 436 439 <span type="species:ncbi:10116">rat</span>
Chronically elevated levels of saturated fatty acids may cause a reduction in beta cell mass during the pathogenesis of type 2 diabetes. Supporting evidence comes primarily from animal models and in vitro studies in which high fatty acid concentrations induce beta cell dysfunction and death [1]-[4]. Depending on the laboratory model, the lipotoxic process is seen (in)dependently of glucotoxic influences [5]. In cultures of purified rat beta cells, we found that palmitate was cytotoxic irrespective of the glucose concentration but that the cells varied in their susceptibility, some of them surviving while others rapidly or progressively proceeded to necrosis or apoptosis [6], [7]. This observation is another illustration of the functional heterogeneity in the beta cell population whereby cells differ in their individual sensitivities and/or defense mechanisms [8]-[10]. Fatty acid (FA) toxicity was found inversely related to the cellular ability to incorporate them as neutral lipids in the cytoplasm [6]. The capacity to form cytoplasmatic lipid droplets may thus serve as a cytoprotective mechanism by preventing accumulation of toxic non-esterified FA [6], [11]. Unsaturated FA such as oleate can channel palmitate into triglyceride pools away from pathways leading to cellular apoptosis [12]-[14]. A second protective mechanism consists in increasing breakdown of fatty acids in the beta cells [15], [16]. We recently demonstrated that the cytoprotective effect of PPARalpha agonists against long-chain fatty acid toxicity is associated with increased rates of beta-oxidation and peroxisomal activity [7]. During the latter study we noticed that PPARalpha agonists also induced a higher expression of stearoyl CoA Desaturase (SCD), which is known to generate monounsaturated FA from palmitate and thus facilitates their incorporation into lipid reserves [17], [18], instead of their accumulation as non-esterified fatty acids or via an increased incorporation in ceramides [19]. Elevated SCD-levels have been shown to protect against saturated fatty acids in a number of cell types, including MIN6 cells [19]-[21]. The present study was undertaken to investigate the potential contribution of SCD in the detoxifying action of PPARalpha agonists.
###end p 4
###begin p 5
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Chu1">[22]</xref>
###xml 341 345 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Kalaany1">[23]</xref>
###xml 347 351 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Lazar1">[24]</xref>
###xml 442 446 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Gerin1">[25]</xref>
###xml 448 452 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Zitzer1">[26]</xref>
Since the SCD1 and 2 enzymes are direct downstream targets of Liver X Receptors (LXR) [22], we started by examining whether LXR agonists can protect beta cells against palmitate through an SCD-dependent mechanism. LXRalpha and LXRbeta are nuclear oxysterol receptors with established roles in cholesterol, lipid, and carbohydrate metabolism [23], [24], and have recently been shown to play an important role in maintaining beta cell function [25], [26].
###end p 5
###begin title 6
Results
###end title 6
###begin title 7
Activation of LXR protects beta cells against palmitate toxicity
###end title 7
###begin p 8
###xml 239 248 223 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g001">Figure 1a</xref>
###xml 557 566 541 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g001">Figure 1a</xref>
###xml 706 715 682 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g001">Figure 1b</xref>
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
###xml 539 544 <span type="species:ncbi:9606">human</span>
Rat beta cells were cultured with palmitate (C16:0) in presence or absence of LXR agonists. Culture with 500 microM palmitate-2 days (500 microM-P) or 250 microM-8 days (250 microM-P) resulted in a cytotoxicity of 29 and 38% respectively (Figure 1a). The LXR agonists TO1317 and GW3965 protected against both conditions keeping cell death below 10%. On the other hand, no protection was seen with the FXR and PXR agonists GW4064 and pregnenolone carbonitrile (PCN), which supports LXR specific protection. TO1317 was also found to protect human beta cells (Figure 1a). The protective effect of TO1317 was maintained over 16 days: 10+/-2% dead cells at 250 microM-P with the agonist versus 55+/-5% without (Figure 1b). Protection was also observed when TO1317 was added 24 h after starting cultures with 250 microM-P: 16+/-8% dead cells after 8 days versus 40+/-5% in its absence (P<0.01) (data not shown). None of the tested agonists influenced beta cell survival in absence of palmitate.
###end p 8
###begin title 9
Agonists for LXR protect primary beta cells against palmitate toxicity.
###end title 9
###begin p 10
###xml 3 6 <span type="species:ncbi:10116">Rat</span>
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 375 378 <span type="species:ncbi:10116">rat</span>
a) Rat and human beta cells were exposed to 500 microM-P, or 250 microM-P in the absence or presence of agonists for LXR (10 microM TO1317 or 1 microM GW3965), FXR (5 microM GW4064), or PXR (30 microM PCN). Data shown as mean+sd, n = 4-10, * p<0.05, ** p<0.01, *** p<0.001, versus palmitate b) Time course over 16 days for the toxicity of 250 microM-P+/-TO1317 (1 microM) in rat beta cells. Data shown as mean+sd, n = 7-10.
###end p 10
###begin p 11
###xml 102 109 98 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007266-t001">Table 1</xref>
Pre-treatment of beta cells with TO1317 also protected against a subsequent exposure to 250 microM-P (Table 1). During a first period of 8 days, beta cells were cultured with or without the agonist; 250 microM-P was added on day 8 and culture continued without agonist. Protection was sustained up to 8 days in cells exposed to palmitate after removal of the protective agonist: 23+/-3% dead cells versus 38+/-3% (P<0.05). Beta cells cultured under control conditions for 8 days showed a comparable cytotoxic response as freshly isolated cells when subsequently exposed to palmitate for 2 to 8 days, indicating that prolonged culture did not alter their susceptibility for palmitate.
###end p 11
###begin title 12
Effect of TO1317 pretreatment on palmitate toxicity.
###end title 12
###begin p 13
Beta cells were pre-cultured for 8 days in absence or presence of 1 microM TO1317 or 250 microM-P; on day 8 these conditions were replaced by the final conditions, as indicated, and the resulting cytotoxicities were measured after 2 or 8 days. Mean+/-SD, n = 4.
###end p 13
###begin p 14
p<0.001, versus control.
###end p 14
###begin p 15
###xml 94 97 90 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Hellemans1">[7]</xref>
###xml 242 250 238 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007266.s002">Table S1</xref>
In contrast to PPARalpha agonists that induce protection to saturated and mono-unsaturated FA [7], TO1317 did not protect against palmitoleate (C16:1), vaccenate (C18:1 n-7) or oleate (C18:1 n-9), while it protected against stearate (C18:0) (Table S1).
###end p 15
###begin title 16
Effect of LXR agonist on intracellular lipid accumulation
###end title 16
###begin p 17
###xml 154 163 150 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g002">Figure 2a</xref>
###xml 239 243 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Karaskov1">[27]</xref>
###xml 245 249 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Moffitt1">[28]</xref>
###xml 394 398 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Moffitt1">[28]</xref>
###xml 588 597 584 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g002">Figure 2a</xref>
In electron microscopy, beta cells exposed to 250 microM-P presented spindle-shaped empty-looking structures associated with the endoplasmatic reticulum (Figure 2a), and that have previously been associated with ER-stress and lipotoxicity [27], [28]; We noticed their presence in living cells, where their abundance seemed increased in the presence of TO1317. As demonstrated by Moffitt et al. [28], these structures correspond to lipid droplets in living cells when examined using light microscopy by vital nile-red staining; their number was markedly increased in the TO1317 condition (Figure 2a). These spindle structures and lipid droplets were not found in control cells cultured with or without TO1317 alone.
###end p 17
###begin title 18
Effect of LXR agonist on intracellular lipid accumulation and palmitate metabolism.
###end title 18
###begin p 19
###xml 290 292 274 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 470 472 448 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 528 530 506 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 543 544 521 522 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 592 593 570 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 707 709 683 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">$$</sup>
###xml 721 724 697 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">$$$</sup>
a) Representative figure showing electron microscopy and vital nile red staining on control cells, and beta cells exposed to 250 microM-P for 2 days+/-TO1317 (10 microM). Magnification: EM 2550x, Nile red (green) + nuclear Hoechst (red) staining: 60x. b) Effect of 250 microM-P+/-TO1317 on 14C-palmitate metabolism. Beta-cells were cultured for 24 h in the absence (white bars) or presence (gray bars) of 250 microM-P+/-TO1317, and subsequently incubated for 2 hrs with 14C-palmitic acid. Metabolism was measured as recovery of 14C-label in CO2, in lipids and lipid intermediates (pmol/2 h/103 cells) and expressed as percentages of the control condition. Data shown as mean+/-se (n = 4), Student's t-test, $$ P<0.01 and $$$ P<0.001, versus control; * P<0.05 and ** P<0.01 versus palmitate.
###end p 19
###begin p 20
###xml 135 137 135 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 213 215 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 217 218 217 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 343 345 335 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 409 418 399 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g002">Figure 2b</xref>
###xml 469 473 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Green1">[29]</xref>
###xml 504 506 494 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 638 640 624 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 642 643 628 629 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 695 697 681 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 774 777 760 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Hellemans1">[7]</xref>
We assessed the effect of TO1317 on the cellular ability to transfer palmitate into cellular lipids, by measuring the incorporation of 14C-palmitate-derived carbon over a period of 2 hrs in cellular lipids, or as 14CO2-production, in control cells and in cells pre-exposed for 24hrs to 250 microM-P. Presence of 1 microM TO1317 stimulated the 14C-flux into lipids by 50+/-16% as compared to control (p<0.01) (Figure 2b). In contrast to the recent study by Green et al. [29], TO1317 was found to suppress 14C-palmitate oxidation in both the palmitate and the control condition. The apparent negative effect of 250 microM-P pre-exposure on 14CO2-formation is explained by a dilution effect on the 14C-label due to the increased intracellular palmitate levels, as shown before [7]. These observations support the view that channeling FA into stored neutral lipids correlates with protection against the cytotoxicity of cytoplasmic free acyl moieties and indicates the involvement of LXR in this process.
###end p 20
###begin title 21
Effect of LXR agonist on mRNA expression of desaturation enzymes in beta cells
###end title 21
###begin p 22
###xml 188 197 188 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g003">Figure 3a</xref>
###xml 345 348 341 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Hellemans1">[7]</xref>
###xml 466 473 458 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007266-t002">Table 2</xref>
We examined the effect of TO1317 on mRNA expression of enzymes involved in fatty acid elongation (ELOvl 5 and 6), desaturation (SCD1 and 2) and esterification (DGAT1 and 2, SOAT 1 and 2) (Figure 3a). Since PPARalpha agonists have been previously found to induce beta cell protection through effects on enzymes that regulate palmitate metabolism [7], we compared the effects of the LXR agonist with those of the PPARalpha agonist combination clofibrate plus 9cis RA (Table 2).
###end p 22
###begin title 23
Enzymes involved in conversion of palmitate in response TO1317.
###end title 23
###begin p 24
###xml 710 711 702 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">$</sup>
###xml 720 723 712 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">$$$</sup>
###xml 432 435 <span type="species:ncbi:10116">rat</span>
a) Overview of enzymes involved in conversion of palmitate (C16:0) to palmitoylate (C16:1), vaccinate (C18:1 n-7), stearate (C18:0) and oleate (C18:1 n-9): stearoyl CoA desaturase (SCD1, SCD2), elongases (ELOvl5, ELOvl6), diacylglycerol transferase (DGAT1, DGAT2), sterol-O-acyl transferase (SOAT1, SOAT2). TG, triglycerides; CE, cholesteryl esters. b) qPCR result examining the mRNA levels of the above enzymes in freshly isolated rat beta cells, alpha-cells and liver, white adipose and brain tissue. Gene expression levels were normalized to actin, n = 3. c) qPCR analysis for SCD1 and 2, showing the effect of 8 days 250 microM-P+/-TO1317. Data shown as mean+/-sd, n = 4, *** p<0.001, compared to control; $ p<0.05, $$$ p<0.001, versus TO1317. d) Representative immunoblot showing SCD protein levels in beta cells cultured for 8 days with or without 250 microM-P+/-TO1317 (10 microM). Equal amounts of total protein were added on a 10% polyacrylamide gel. Representative for 4 independent experiments.
###end p 24
###begin title 25
Effect of palmitate and LXR or PPARalpha agonists on gene mRNA expression levels calculated as DeltaDeltaCt values compared to the indicated control conditions.
###end title 25
###begin p 26
Beta cells were exposed for 2 days to 250 microM-P+/-1 microM TO1317, or 250 microM clofibrate/2 microM 9-cis RA. qPCR values were normalized to actin and compared relative to the respective control conditions. Unpaired student t-test, two tailed, mean+/-SD, n = 4 - 6, * p<0.05, ** p<0.01, *** p<0.001.
###end p 26
###begin p 27
###xml 310 319 310 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g003">Figure 3b</xref>
###xml 422 429 418 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007266-t002">Table 2</xref>
###xml 586 593 578 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007266-t002">Table 2</xref>
###xml 789 803 781 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g003">Figures 3c, 3d</xref>
###xml 924 931 912 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007266-t002">Table 2</xref>
###xml 1108 1115 1088 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007266-t002">Table 2</xref>
###xml 1316 1320 1292 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Chu1">[22]</xref>
When beta cells are compared with liver, brain, white adipose tissue (WAT) and endocrine alpha cells, they exhibit a high expression of SCD2, FA elongase-5 (ELOvl5) and sterol-O-acyl transferase-1(SOAT1), and a low expression of SCD1, ELOvl6, and the diacyl glycerol acyltransferase-1 and 2 (DGAT1 and DGAT2) (Figure 3b). Two days culture with 250 microM-P suppressed expression of SCD1 and 2 by, respectively 50 and 30% (Table 2); in presence of TO1317 these expressions were 5 and 3-fold higher than in its absence; a stimulation was also seen with the PPARalpha agonist combination (Table 2), but not observed in the presence of 9cis RA alone (results not shown). The effect of TO1317 on mRNA expression of SCD1 and SCD2 was accompanied by a similar effect on their protein expression (Figures 3c, 3d). The presence of 250 microM-P did not significantly alter the expression of the elongation and esterification enzymes (Table 2). It was however found to reduce the expression of the transcription factors PPARalpha and FXR, an effect that was counteracted by the presence of an LXR or PPARalpha agonist (Table 2). Both agonists also caused a marked increase in the expression of SREBP1c, which is compatible with the earlier reported role of SREBP1c in controlling SCD expression downstream of PPARalpha and LXR [22].
###end p 27
###begin p 28
###xml 198 205 194 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007266-t002">Table 2</xref>
###xml 261 263 257 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 286 295 282 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g002">Figure 2b</xref>
In contrast to PPARalpha agonists, the LXR agonist did not stimulate expression of enzymes involved in mitochondrial and peroxisomal oxidation. On the contrary, inhibitions up to 40% were measured (Table 2), which is compatible with the observed suppression of 14C-palmitate oxidation (Figure 2b).
###end p 28
###begin title 29
Inhibition of stearoyl-coenzyme A desaturase reverses the cytoprotective effects of LXR and PPARalpha agonists in beta cells
###end title 29
###begin p 30
###xml 156 157 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 160 161 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 233 234 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 236 237 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 281 285 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Busch1">[20]</xref>
###xml 431 432 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 435 436 427 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 580 581 568 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 583 584 571 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 592 601 580 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g004">Figure 4a</xref>
###xml 972 973 960 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 976 977 964 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 1147 1156 1131 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g004">Figure 4a</xref>
###xml 1500 1501 1484 1485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1504 1505 1488 1489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 287 290 <span type="species:ncbi:10116">Rat</span>
###xml 818 821 <span type="species:ncbi:10116">rat</span>
###xml 956 959 <span type="species:ncbi:10116">rat</span>
###xml 1012 1017 <span type="species:ncbi:9606">human</span>
###xml 1457 1460 <span type="species:ncbi:10116">rat</span>
In view of their effects on expression of SCD1 and SCD2 we examined whether the cytoprotective effects of the LXR and PPARalpha agonists were influenced by t10,c12-conjugated linoleic acid, a known inhibitor of SCD, or by its analog c9,t11-CLA, which has no effect on SCD activity [20]. Rat beta cells were cultured with 250 microM-P plus TO1317 for 8 days in the presence or absence of one of these compounds. The SCD-active CLA (t10,c12-CLA - 40 microM) not only prevented the protective effect of TO1317 but also augmented palmitate cytotoxicity, while no effect was seen with c9,t11-CLA (Figure 4a). This was also the case for the clofibrate-retinoic acid combination. None of the CLA-compounds were toxic by themselves, while they showed a mild protective effect on palmitate toxicity in the absence of TO1317 in rat beta cells. At this moment we can only speculate why both the active and the inactive CLA-isomers provided protection to palmitate in rat beta cells. t10,c12-CLA did not show this effect on human cells where it was - as expected - found to increase 250 microM-P toxicity in the presence, as well as in the absence of TO1317 (Figure 4a). Up to 5 different SCDs have been described in mammals with their own specific FA-preferences, whereas the effects of the CLAs have only been described for SCD1. It can thus not be excluded that other SCDs could be influenced by CLA treatment, and may affect palmitate toxicity. Our observations in rat beta cells indicate that the action of t10,c12-CLA on palmitate toxicity depends on the induction of SCD1 and SCD2 by TO1317, whereas cell survival in the absence of TO1317 does not depend on basal desaturase activity.
###end p 30
###begin title 31
Delta9-desaturase activity plays a key role in protection against palmitate toxicity.
###end title 31
###begin p 32
###xml 167 168 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 170 171 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 194 195 168 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 198 199 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 443 444 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 447 448 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 659 668 617 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007266.s001">Figure S1</xref>
###xml 32 35 <span type="species:ncbi:10116">Rat</span>
###xml 40 45 <span type="species:ncbi:9606">human</span>
a) Effect of inhibition of SCD. Rat and human beta cells were exposed to 250 microM-P or 500 microM-P+/-10 microM TO1317 or 250 microM clofibrate/2 microM 9RA, and/or c9,t11 CLA (40 microM), or t10,c12 CLA (40 microM). Percentage cytotoxicity shown as mean+sd, n = 3-4, *** p<0.001, versus palmitate. b) Effect of treatment on fatty acid composition as measured by GC-MS. Beta cells were exposed to 250 microM-P+/-10 microM TO1317 and+/-40 nM t10,c12 CLA for 8 days. The levels for C16:0, C18:0, C16:1, C18:1 and C20:4 measured as nmol/nmol Pi were expressed relative to their levels in control cells (ratios of saturated over monounsaturated FA are shown in Figure S1). Mean+/-sd, n = 4 - 6, * p<0.05 versus control, $ p<0.05 versus palmitate. c) RNA interference. Beta cells were transfected with a pool of siRNA's directed against SCD1 and 2 (Si-SCD1/SCD2), and exposed to 250 microM-P and/or TO1317 for 3 days. Si-control cells were treated with lipid transfection carrier (jetsi endo) only, or a pool of siGlo risk-free siRNA's (siGlo). Percentage cytotoxicity shown as mean+sd, n = 4, * p<0.05, *** p<0.001, versus Si-control cells.
###end p 32
###begin p 33
###xml 20 21 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 24 25 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 438 448 438 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007266.s001">Figure S1a</xref>
###xml 575 584 571 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g004">Figure 4b</xref>
###xml 1283 1284 1267 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1287 1288 1271 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 1368 1378 1352 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007266.s001">Figure S1b</xref>
The SCD-active CLA (t10,c12 CLA) interfered with the effects of TO1317 on palmitate conversion as illustrated by GC-MS profiles of beta cells following culture. In the absence of palmitate and TO1317, beta cells exhibited comparable levels of C16:0, C18:0 (stearic acid) and arachidonic acid (C20:4), whereas their levels of C18:1 n-9 (oleic acid) and C18:1 n-7 (vaccenic acid) were lower, and those of C16:1 (palmitoleic acid) very low (Figure S1a). Culture with 250 microM-P led to a marked increase of the C16:1 fraction, and lowered C18:0 and C18:1 (n-7 and n-9) levels (Figure 4b). Consistent with a stimulatory effect on SCD, addition of TO1317 was found to normalize the C18:1 n-7 levels, but did not prevent the changes in C18:0, C18:1 n-9 and C16:1. The SCD-active CLA counteracted the effect of TO1317 on C18:1 n-7, and blocked formation of C16:1 and C18:1 n-9. No change was seen for the levels of C20:4 (arachidonic acid), a fatty acid derived from C18:2 (linoleic acid) through Delta5- and Delta6-desaturases, further indicating specific involvement of the Delta9 desaturase pathway. We noticed a higher C16:0 peak area after palmitate exposure, but it is impossible to discriminate whether this reflects uptake or adherence of the fatty acid. The effects of TO1317 and t10,c12 CLA on the ratios of saturated over monounsaturated fatty acids are shown in Figure S1b.
###end p 33
###begin p 34
###xml 786 795 770 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g004">Figure 4c</xref>
###xml 994 1003 976 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g004">Figure 4c</xref>
The role of SCD in beta cell protection against palmitate was further examined by RNA interference with this protein. Exposure of beta cells for 48 h to 50 nM siRNA-cationic lipid complexes targeted to both SCD1 and SCD2 resulted in a significant decrease in SCD-RNA levels (by 78+/-3% for SCD1, and 51+/-12% for SCD2 respectively), without affecting SREBP1c, LXR and PPARalpha mRNA levels (not shown). Jetsi-ENDO control and SiGLO risk free treated cells were used as control. Cell viability was not affected by the transfection protocol, and siRNA knock-down of SCD did not affect cell viability when compared to controls. Under these conditions, cells were taken 24 h after transfection and cultured for 72h in presence or absence of 250 microM-P with or without TO1317 (10 microM) (Figure 4c). SCD1/SCD2 siRNA-treated beta cells showed an increased palmitate toxicity (47+/-8%) as compared to control-transfected cells (Jetsi-ENDO control and SiGLO risk-free treated cells, p<0.05, n = 4) (Figure 4c). Moreover, protection by TO1317 was lost in SCD1/SCD2 siRNA-treated beta cells. Comparable results were obtained when cells were transfected with siRNAs directed to either SCD1 or SCD2 (data not shown). Cell viability was not affected by the transfection protocol, and siRNA knock-down of SCD did not affect cell viability when compared to controls.
###end p 34
###begin title 35
Interaction between desaturation pathway and palmitate induced ER stress
###end title 35
###begin p 36
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Karaskov1">[27]</xref>
###xml 141 145 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Moffitt1">[28]</xref>
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Cnop3">[30]</xref>
###xml 234 242 234 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g002">Figure 2</xref>
###xml 498 505 498 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007266-t003">Table 3</xref>
###xml 860 867 856 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007266-t003">Table 3</xref>
###xml 1165 1169 1153 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Larade1">[31]</xref>
###xml 1288 1291 1276 1279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 1372 1376 1360 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Zhang1">[32]</xref>
###xml 1525 1532 1505 1512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007266-t003">Table 3</xref>
###xml 513 516 <span type="species:ncbi:10116">rat</span>
A causal relation between palmitate toxicity, ER stress and the accumulation of spindle-shaped structures in the ER has been suggested [27], [28], [30]. In our experiments these structures accumulated under protective conditions (See Figure 2). We therefore studied the expression of ER-stress markers in response to palmitate with, or without TO1317. Using this strategy we could, however, not establish a clear correlation between ER-stress, palmitate induced toxicity and protection against it (Table 3). When rat beta cells were exposed to 500 microM-P for 2 days - a condition with acute cell death- the expression levels of DNA-damage inducible transcript 3 (Ddit3/Chop) were found increased, in the absence, as well as in the presence of TO1317, while those of DnaJ homologue C3 (DnaJc3/P58) and heat shock 70 kDa protein 5 (HSPA5) remained unaffected (Table 3). No changes in expression for ER stress markers were found when cells were exposed to 250 microM-P with or without TO1317. We therefore further addressed this question by looking upstream from SCD. Delta9-desaturation requires electrons supplied via Ncb5or (NAD(P)H-cytochrome b5 oxidoreductase) [31]. Ncb5or was recently found to protect cells against palmitate induced ER-stress and lipotoxicity. Cells lacking Ncb5or-/- show more signs of ER stress and a higher cytotoxicity in response to palmitate [32]. We found the expression levels of Ncb5or induced by TO1317 in presence of 250 microM and 500 microM-P, but not influenced by palmitate on its own (Table 3). These observations are consistent with a role of SCD to channel palmitate into less harmful pathways such as accumulation into neutral lipids, and -in our view- dissociate the accumulation of these lipids in the ER from apoptosis, since more of these spindle-shaped structures were formed under protective conditions.
###end p 36
###begin title 37
Effect of palmitate and LXR agonists on genes related to ER-stress.
###end title 37
###begin p 38
qPCR values normalized against actin and expressed relative to the control condition (vehicle treated). Cells were exposed for 2 days to 250 microM-P or 500 microM-P with or without 10 microM TO1317. Student t-test, two tailed, mean+/-sd, N = 3 - 6, * p<0.05, ** p<0.01.
###end p 38
###begin title 39
LXR isotype specificity in modulation of palmitate toxicity through SCD and SREBP1
###end title 39
###begin p 40
###xml 119 122 111 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 131 134 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 148 151 130 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 385 394 363 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g005">Figure 5a</xref>
###xml 420 423 395 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 440 443 408 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 581 584 545 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 658 667 622 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g005">Figure 5a</xref>
###xml 970 973 923 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 982 985 932 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 1002 1005 945 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 1007 1016 950 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g005">Figure 5a</xref>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
###xml 845 849 <span type="species:ncbi:10090">mice</span>
The cytoprotective effects of LXR and PPARalpha agonists were measured in beta cell preparations isolated from LXRalpha-/-, LXRbeta-/-, LXRalphabeta-/- and wild type mice. Beta cell survival in control conditions was similar for the 4 genotypes and was not influenced by the presence of TO1317 or clofibrate/9-cis RA. Culture with 250 microM-P was cytotoxic for the four preparations (Figure 5a). Beta cells from LXRbeta-/- and LXRalphabeta-/- mice showed a much higher susceptibility to palmitate-toxicity (almost 100% cell death) than wild type cells, whereas those from LXRalpha-/- mice were less susceptible. No differences in oleate toxicity were seen (Figure 5a). The same observations were made when cells were exposed to 100 microM-P, leading to almost 70% cell death in absence of LXRbeta (results not shown). Beta cells from wild-type mice were strongly protected by the LXR-agonist TO1317, as well as by clofibrate/9-cis RA. This was not the case for LXRalpha-/-, LXRbeta-/- and LXRalphabeta-/- (Figure 5a). These observations indicate that the protective action of PPARalpha agonists on palmitate toxicity depend on the presence of both LXRalpha and beta and downstream signaling pathways.
###end p 40
###begin title 41
Effect of LXR and PPARalpha agonists on palmitate toxicity in LXR KO beta cells.
###end title 41
###begin p 42
###xml 289 292 269 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">$$$</sup>
###xml 327 330 307 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 396 399 376 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
Primary mouse beta cells were exposed to a) 250 microM-P or 250 microM oleate for 8 days in presence or absence of 1 microM TO1317 or 250 microM clofibrate/2 microM 9-cis RA. Percentages of cytotoxicity are shown as mean+sd, n = 3, *** p<0.001, TO1317 and clofibrate/9RA versus palmitate; $$$ p<0.001, palmitate toxicity in LXR-/- as versus wild type. b) SCD1, SCD2 and SREBP1c mRNA levels in LXR-/- islets as compared to wild type. Q-PCR signals shown as mean+sd, n = 3, * p<0.001.
###end p 42
###begin p 43
###xml 84 88 80 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-,</sup>
###xml 96 99 89 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 113 116 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 137 145 123 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007266.s003">Table S2</xref>
###xml 390 393 372 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 505 514 484 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g005">Figure 5b</xref>
###xml 568 576 547 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007266.s003">Table S2</xref>
###xml 817 821 789 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Repa1">[33]</xref>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
We also conducted the above-described mRNA analysis on islets isolated from LXRalpha-/-, LXRbeta-/-, LXRalphabeta-/- and wild type mice (Table S2). The islets did not present obvious differences in cellular composition with more than 65% percent beta cells in each preparation (results not shown). No significant differences were noticed between islets from wild-type mice and from LXRalpha-/-mice, while absence of LXRbeta was associated with a markedly reduced expression of SCD1 and 2, and of SREBP1c (Figure 5b), and higher expression of DGAT1, SOAT1, and ELOvl5 (Table S2). This observation is compatible with a key role of LXRbeta in the expression of SCD and SREBP1c, and their influence on the cellular susceptibility to palmitate toxicity and further supports a role of SREBP1c downstream of LXR < PPARalpha [33].
###end p 43
###begin title 44
Correlation between SCD expression in isolated beta cells and their susceptibility to palmitate
###end title 44
###begin p 45
###xml 141 144 <span type="species:ncbi:10116">rat</span>
The view that SCD-expression in beta cells may vary with their environmental conditions in vivo, led us to explore three conditions in which rat beta cells could be expected to express higher SCD-levels after isolation. These preparations were then analyzed for their susceptibility to palmitate toxicity.
###end p 45
###begin p 46
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The first condition</italic>
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Biddinger1">[34]</xref>
###xml 307 311 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Wahle1">[35]</xref>
###xml 521 530 509 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g006">Figure 6a</xref>
###xml 533 541 521 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007266.s004">Table S3</xref>
###xml 868 877 840 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g006">Figure 6b</xref>
###xml 1193 1194 1165 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1197 1198 1169 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 76 80 <span type="species:ncbi:10116">rats</span>
###xml 1342 1346 <span type="species:ncbi:10116">rats</span>
The first condition is represented by beta cells isolated from Zucker fatty rats lacking leptin receptor (fa/fa). Since leptin suppresses SCD [34] these animals show increased Delta9-desaturation activities and decreased saturated/mono-unsaturated fatty acid ratios in serum and tissues, including pancreas [35]. Compare to their lean controls (fa/-), beta cells from fa/fa animals showed 2-fold higher mRNA levels for SCD1, SCD2; their LXRalpha expression was also elevated, whereas PPARalpha expression was suppressed (Figure 6a), Table S3. Beta cells isolated from fa/fa animals showed a significantly lower susceptibility to palmitate-induced cell death than those isolated from lean controls (fa/-): after 8 days the cytotoxicity of 250 microM-P and 500 microM-P was, respectively, 6+/-2% and 13+/-1% for in fa/fa versus 28+/-4% and 48+/-5% in the fa/- controls (Figure 6b). In contrast, the cytotoxicity of oleate was low and similar in both preparations. When the LXR-agonist TO1317 was added to the palmitate conditions, it gave a mild reduction of palmitate toxicity in fa/fa beta cells, whereas fa/- cells were efficiently protected. Protection was counteracted by the SCD inhibitor t10,c12 CLA which even amplified the palmitate toxicity in both cell preparations. Beta cell vitalities of cells isolated from lean and Fatty Zucker rats were similar in control conditions. These data indicate that differences in SCD expression and activity in beta cells have consequences for their susceptibility to saturated fatty acids.
###end p 46
###begin title 47
SCD levels regulate beta cell susceptibility for palmitate in vivo.
###end title 47
###begin p 48
###xml 250 251 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 254 255 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 949 952 915 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Martens1">[8]</xref>
###xml 111 115 <span type="species:ncbi:10116">rats</span>
###xml 409 420 <span type="species:ncbi:10116">Wistar rats</span>
Beta cells and alpha-enriched cell preparations were obtained from: a-b) Zucker fatty (fa/fa) and lean control rats (fa/-) and exposed for 8 days to 250 microM and 500 microM palmitate or oleate in the presence or absence of 10 microM TO1317+/-40 nM t10,c12 CLA. Percentages of cytotoxicity are shown as mean+/-sd, n = 3, * p<0.001 fa/fa versus lean control, $ p<0.001 versus palmitate; or isolated from c-d) Wistar rats treated by oral gavages for 5 days with 40mg/kg BW TO1317 or vehicle (DMSO/PBS, 1/3), and exposed for 2 days to 500 microM palmitate or oleate in the presence or absence of 1 microM TO1317 or 250 microM clofibrate +2 microM 9-cis RA. Results are shown as mean+/-sd, n = 3, * p<0.001 TO1317-cells versus vehicle, $ p<0.001 versus control; or e-f) Beta cells were FACS sorted based on their glucose-induced increase in [NAD(P)H]-autofluorescence into two subpopulations characterized by a high or low glucose-responsive phenotype [8], and exposed for 8 days to 250 microM palmitate or oleate in the presence or absence of 1 microM TO1317 or 250 microM clofibrate plus 2 microM 9-cis RA. Percentages of cytotoxicity are shown as mean+/-sd, n = 3, * p<0.01 low versus high NAD(P)H-cells; $ p<0.01 agonist treatment versus control. a,c,e) Q-PCR analysis showing the differences in expression levels of glucokinase, SCD1, SCD2, LXRalpha, LXRbeta, PPARalpha and SREBP1c. Results are shown as mean+/-sd, n = 3-7, * p<0.05, ** p<0.01 versus the respective control preparations.
###end p 48
###begin p 49
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The second condition</italic>
###xml 431 440 420 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g006">Figure 6c</xref>
###xml 753 762 738 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g006">Figure 6d</xref>
###xml 1180 1183 1157 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Hellemans1">[7]</xref>
###xml 64 68 <span type="species:ncbi:10116">rats</span>
###xml 319 323 <span type="species:ncbi:10116">rats</span>
###xml 1271 1275 <span type="species:ncbi:10116">rats</span>
###xml 1519 1523 <span type="species:ncbi:10116">rats</span>
The second condition was experimentally induced by treatment of rats with the LXR agonist TO1317 (40 mg/kg body weight by oral gavage for 5 days) or with a control vehicle. The pancreases were then removed for purification of beta cells and alpha cell enriched fractions by FACS-sorting. Beta cells from TO1317-treated rats showed elevated SCD1, SCD2 and SREBP1c mRNA levels, and similar levels of LXRalpha, LXRbeta and PPARalpha (Figure 6c). Their palmitate susceptibility was lower after 500 microM-P -2 days but could not be further reduced by addition of LXR or PPARa agonists, while these compounds induced protection in the vehicle-derived beta cells. Cells from TO1317-treated and vehicle-treated animals showed the same low oleate cytotoxicity (Figure 6d). Comparable data were obtained after culture at 250 microM-P for 8 days (cytotoxicity of 10+/-3% in TO1317-cells versus 30+/-1% in vehicle-cells). These observations indicate that in vivo treatment with the LXR-agonist has induced a beta cell phenotype with a sustained protection against palmitate. In prior work we showed that clof/9-cis RA did not influence palmitate toxicity in alpha-cell enriched preparations [7]. In the present study alpha-cell enriched preparations from TO1317- or vehicle-treated rats exhibited the same palmitate toxicity; this was also the case when TO1317 was added to the culture medium. No differences were seen in the viability of the beta cell or alpha cell-enriched preparations isolated from TO1317- or vehicle-treated rats and cultured in the control condition
###end p 49
###begin p 50
###xml 169 172 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Hellemans1">[7]</xref>
###xml 203 227 203 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and as a third condition</italic>
###xml 439 442 439 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Martens1">[8]</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Ling1">[36]</xref>
###xml 693 702 689 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g006">Figure 6e</xref>
###xml 704 708 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Heimberg1">[37]</xref>
###xml 791 800 783 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g006">Figure 6f</xref>
###xml 264 267 <span type="species:ncbi:10116">rat</span>
In prior work we have shown that primary beta cells can be less susceptible or even resistant to palmitate toxicity, and that this property is heterogeneously expressed [7]. To explore this observation, and as a third condition, we have separated freshly isolated rat beta cells into two subpopulations according to their cellular metabolic responsiveness to an acute 7.5 mM glucose stimulation, as described in prior studies by our group [8], [36]. The high-responsive beta cells were found to express higher levels of SCD1 and LXRalpha than the low-responsive beta cells; their higher expression of glucokinase was confirmed and served as an index for their higher metabolic responsiveness (Figure 6e) [37]. They also presented a lower cytotoxicity after 8 days culture with 250 microM-P (Figure 6f), or 2 days with 500 microM-P (data not shown). Addition of the LXR- or PPARalpha-agonists exerted a much more pronounced protective effect in the low-responsive subpopulation, which is in part related to their higher palmitate toxicity but which also indicates that they can generate cytoprotective mechanisms when receiving extracellular signals. As with the previously described conditions, the two tested cell populations underwent a similar low oleate cytotoxicity.
###end p 50
###begin title 51
Discussion
###end title 51
###begin p 52
###xml 454 458 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Tenenbaum1">[38]</xref>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Finegood1">[39]</xref>
###xml 554 558 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Gerin1">[25]</xref>
###xml 560 564 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Zitzer1">[26]</xref>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Zitzer1">[26]</xref>
###xml 670 674 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Green1">[29]</xref>
###xml 676 680 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Efanov1">[40]</xref>
###xml 824 828 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Laffitte1">[41]</xref>
###xml 830 834 830 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Cao1">[42]</xref>
The mechanisms regulating the balance between functional adaptation, lipid accumulation, dysfunction, or beta cell death in response to chronic elevated FA levels are poorly understood. Clarifying these mechanisms could help to develop new strategies to prevent beta cell deterioration in type 2 diabetes. Several studies have reported the potential of PPAR ligands to preserve functional beta cell mass in obesity models and in clinical type 2 diabetes [38], [39], but only a limited number of reports has characterized the role of LXRs in this context [25], [26]. LXR activation has been shown to stimulate insulin secretion in vitro via de novo lipid synthesis [26], [29], [40], while in vivo LXR agonists are shown to reduce serum glucose levels and to improve glucose tolerance and insulin resistance in obesity models [41], [42].
###end p 52
###begin p 53
###xml 369 372 362 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Hellemans1">[7]</xref>
###xml 480 484 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Pinnamaneni1">[19]</xref>
###xml 485 489 474 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Peter1">[21]</xref>
###xml 745 753 726 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007266-g007">Figure 7</xref>
###xml 1407 1411 1380 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Green1">[29]</xref>
###xml 1413 1417 1386 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Kumadaki1">[43]</xref>
###xml 1419 1423 1392 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Shimano1">[44]</xref>
###xml 1622 1626 1591 1595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Green1">[29]</xref>
###xml 1628 1632 1597 1601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Kumadaki1">[43]</xref>
###xml 1634 1638 1603 1607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Choe1">[45]</xref>
###xml 1978 1982 1947 1951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Busch1">[20]</xref>
###xml 2056 2060 2025 2029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Morgan1">[46]</xref>
###xml 625 630 <span type="species:ncbi:9606">human</span>
We have used primary beta cell preparations to examine ways to induce protection against beta cell death during prolonged exposure (up to 16 days) to elevated concentrations of the saturated fatty acid palmitate. Protection was seen with PPARalpha agonists and correlated with an increased oxidation rate and an increased expression of genes involved in beta-oxidation [7], as well as in Delta9-desaturation and lipogenesis. In view of the prior reported protective action of SCD [19]-[21], which is mainly a LXR target gene, we now demonstrate that both PPARalpha and LXR-agonists provide long-term protection in rodent and human beta cells through a pathway involving Delta9-desaturation. We propose the following model (schematic overview in Figure 7): Delta9-desaturase expression in beta cells is regulated by LXR. Direct activation of LXR, or induction of LXR downstream of PPARalpha regulates SCD-transcription, possibly in a SREBP1c-dependent way. As a result exogenous palmitate is desaturated, elongated and more efficiently channeled to neutral storage pools associated with detoxification. This view is supported by the observation that TO1317 confers protection to saturated, but not to monounsaturated FA; and by the increased toxicity of palmitate upon SCD inhibition, or by its silencing. SREBP1c, known to regulate ELOvl6 (which preferentially elongates C16>C18), as well as SCD-expression [29], [43], [44], GPAT and DGAT2, both involved in triglyceride formation, were all induced in response to both LXR and PPARalpha ligands, consistent with an accumulation of palmitate into intracellular lipid pools [29], [43], [45]. Our observations unambiguously indicate the involvement of SCD in this process but do not exclude that protection against palmitate could lay at a step between fatty acid desaturation and incorporation of unsaturated fatty acids into neutral lipids. Deposition into neutral lipids was not essential to induce SCD-protection in Min6 cells [20]. Newly formed monounsaturated FA could exert specific protective effects [46].
###end p 53
###begin title 54
Hypothetical lipoprotection model using LXR or PPAR ligands.
###end title 54
###begin p 55
Long chain saturated FA, such as palmitate, induce cell death through reactive intermediates, ceramide generation or via ER stress. Activation of LXR downstream of PPARalpha activates SREBP1c and induces transcription of genes encoding SCD1 and SCD2. This results in an increased formation of monounsaturated FA and directs the flow of palmitate towards intracellular storage as neutral lipids. Next to inducing SCD levels, activation of PPARalpha results in an increased turn-over of FA by stimulation of beta-oxidation, with detoxifying effects on both saturated and monounsaturated FA.
###end p 55
###begin p 56
###xml 215 219 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Francis1">[47]</xref>
###xml 544 548 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Lalloyer1">[48]</xref>
###xml 579 582 559 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Hellemans1">[7]</xref>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
Absence of LXR abolished protection to palmitate by TO1317, as well as by clofibrate/9-cis RA. This observation indicates that PPARalpha modulates LXR-expression in beta cells, as already shown for other cell types [47]. PPARalpha agonists were indeed found to induce LXRalpha mRNA levels. These findings further imply that PPARalpha-induced protection to saturated FFA largely depends on LXR-regulated SCD and not on its stimulatory action on fatty acid oxidation. In contrast to LXR, ligands for PPARalpha however not only detoxify saturated [48], but also monounsaturated FFA [7], indicating that an increased oxidation rate contributes to gain protection. Islets from mice lacking LXRbeta showed a strong suppression of SCD and SREBP1c correlating with an increased susceptibility to palmitate, but not oleate, which further emphasizes the importance of Delta9-desaturation.
###end p 56
###begin p 57
###xml 602 606 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Repa1">[33]</xref>
###xml 608 612 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Qin1">[49]</xref>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
Although the expression levels of LXRalpha seem to correlate with resistance to cytotoxicity, our results using LXR knock-out mice imply that both LXRalpha and LXRbeta are required to gain protection by LXR or PPAR ligands, whereas LXRbeta seems to control basal transcription from the SCD-promoter via SREBP1c. These results point to a complex regulation of the SCD promoter in response to LXRs, PPARs and SREBP1c. Comparable observations, where both LXR subtypes are required to control transcription in concert with PPAR and/or SREBP1c, have been reported for Elovl5, Delta6-desaturase and SREBP-1c [33], [49].
###end p 57
###begin p 58
###xml 236 240 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Zitzer1">[26]</xref>
###xml 242 246 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Green1">[29]</xref>
###xml 248 252 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Diraison1">[50]</xref>
###xml 564 568 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Diraison2">[51]</xref>
###xml 569 573 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Kato2">[56]</xref>
###xml 765 769 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Parton1">[57]</xref>
###xml 991 995 987 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Zitzer1">[26]</xref>
###xml 997 1001 993 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Green1">[29]</xref>
###xml 1191 1195 1187 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Choe1">[45]</xref>
###xml 1197 1201 1193 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Wente1">[58]</xref>
###xml 1203 1207 1199 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Meng1">[59]</xref>
###xml 1603 1607 1594 1598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Green1">[29]</xref>
###xml 1628 1632 1619 1623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Hu1">[60]</xref>
###xml 2014 2018 2005 2009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Lai1">[61]</xref>
###xml 2632 2636 2619 2623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Ide1">[62]</xref>
###xml 553 557 <span type="species:ncbi:10116">rats</span>
###xml 928 933 <span type="species:ncbi:10090">mouse</span>
###xml 1710 1713 <span type="species:ncbi:10116">rat</span>
###xml 2069 2074 <span type="species:ncbi:9606">human</span>
###xml 2313 2316 <span type="species:ncbi:10116">rat</span>
###xml 2318 2323 <span type="species:ncbi:10090">mouse</span>
###xml 2328 2333 <span type="species:ncbi:9606">human</span>
In the proposed model SREBP1c seems to play a central role downstream from PPARalpha and LXR. SREBP1c activation has already been implicated in the adaptive changes that underlie beta cell hypersecretion in response to elevated glucose [26], [29], [50]. In contrast however, hyper-activation of SREBP1c by its over expression or its activation by glucose and/or palmitate, has been linked to glucolipotoxicity, suppression of glucose-stimulated insulin secretion (GSIS), and was proposed as a mechanism to explain islet failure in Zucker Diabetic fatty rats (ZDF) [51]-[56]. Inactivation of SREBP1c in these islets, however, failed to normalize GSIS, thereby excluding SREBP1 and triglyceride-accumulation as the main cause behind defective secretion in this model [57]. Consistent with a role for SREBP1c in controlling insulin secretion, TO1317 has been shown to stimulate GSIS and insulin biosynthesis in beta cell lines and mouse islets via a stimulation of glucose and lipid metabolism [26], [29]. Negative effects of TO1317 on cellular vitality and/or beta cell proliferation were however also reported and need attention when LXR agonists would be considered to treat type 2 diabetes [45], [58], [59]. We therefore examined TO1317+/-palmitate for a period up to 16 days; no adverse effects on cell viability and cell numbers were observed, and palmitate toxicity was suppressed by an average of 88% during the whole period. In this context it also needs to be mentioned that TO1317 was recently found, in parallel to SCD1, to induce CPT1 mRNA levels and to stimulate beta-oxidation in INS1-cells [29], and in hepatocytes [60], whereas TO1317 showed the opposite effects in our experiments using primary rat beta cells. These divergent results could relate to differences in experimental protocols such as FFA concentrations, FFA/BSA ratio's, use of serum, or relate to differences in levels and duration of LXR-activation, but also point to differences between beta cell lines and primary cells. Lai et al. [61] recently postulated that the lower sensitivity of human beta cells and Min6 cells to palmitate toxicity as compared to INS-I cells, could be related to higher SCD1 levels. In our experiments however, comparable cytotoxic responses to palmitate (250 and 500 microM) were found for FACS-purified rat, mouse and human beta cells. Comparison of the expression profiles of primary cells and cell lines in response to FA and agonists might reveal differences explaining these divergent observations. Cross talk between PPAR- and LXR-levels and competition to bind RXRs or with other nuclear receptors could play a role [62].
###end p 58
###begin p 59
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Busch1">[20]</xref>
###xml 442 446 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Chu2">[63]</xref>
###xml 448 452 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Kakuma1">[64]</xref>
###xml 994 999 990 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</sup>
###xml 1062 1066 1058 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Flowers2">[65]</xref>
###xml 1365 1369 1357 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Flowers2">[65]</xref>
###xml 1708 1711 1700 1703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Hellemans1">[7]</xref>
###xml 1918 1922 1910 1914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Wang2">[66]</xref>
###xml 2266 2270 2258 2262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-GutierrezJuarez1">[67]</xref>
###xml 2272 2276 2264 2268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Jiang1">[68]</xref>
###xml 2583 2587 2575 2579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Moloney1">[69]</xref>
###xml 2589 2593 2581 2585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Riserus1">[70]</xref>
###xml 731 735 <span type="species:ncbi:10116">rats</span>
###xml 1000 1004 <span type="species:ncbi:10090">mice</span>
###xml 1779 1783 <span type="species:ncbi:10090">mice</span>
###xml 2510 2518 <span type="species:ncbi:9606">patients</span>
Busch et al. reported that palmitate-resistant Min6 cells were mainly characterized by an increase of SCD1 [20]. Our study cannot discriminate between the respective contribution of SCD1 or SCD2. Whereas SCD2 was more prevalent in freshly isolated beta cells, SCD1 was induced more potently by LXR and PPARalpha. SCD1 contains SREBP1c and LXR-responsive elements in its promoter region, whereas its expression is actively repressed by leptin [63], [64]. Activation of SCD in animals lacking normal leptin signaling can thus be predicted to lower the cellular susceptibility to toxic palmitate concentrations. This hypothesis is supported by our observations on beta cells isolated from TO1317-treated animals and from Zucker fatty rats (lacking a functional leptin receptor), which were protected from palmitate but not oleate toxicity, and by a rise of palmitate toxicity in the presence of an SCD-inhibitor. The importance of SCD in beta cells is also documented by the loss of SCD1 in leptinob/ob mice, leading to an accelerated progression to overt diabetes [65]. Absence of SCD in this model was accompanied by appearance of a morphologically distinct class of dysfunctional islets showing a suppression of PPARalpha and its target genes, increased triglycerides, FFA, and higher levels of saturated FA than a second class of islets displaying normal features [65]. These observations are also interesting in view of the differences in palmitate susceptibility and SCD1 expression levels observed in the high and low glucose-responsive beta cells, and in view of our prior work where it was shown that primary beta cells show differences in susceptibility or can even be resistant to palmitate toxicity [7]. Recent observations in leptin receptor-overexpressing obese db/db mice showed suppressed SREBP1c and adipogenic gene-expression levels, severe diabetes and beta cell loss 6 weeks before the db/db controls [66]. These findings support the idea that the inherent adipogenic phenotype of individual beta cells via chain elongation and desaturation provides the cells with a protective mechanism to cope with elevated FFA. Our observations contain an important message since SCD1-inhibitors are evaluated to treat obesity and the related metabolic syndrome [67], [68]. Although suppression of SCD1 might show beneficial effects on adiposity, these benefits may come at the expense of pancreatic beta cells. Clinical studies already indicated an increased risk to develop diabetes in predisposed obese patients using a mixture of c9,t11 and t10,c12 CLA for weight management [69], [70].
###end p 59
###begin p 60
In conclusion, activation by PPAR and LXR agonists of a pathway controlled by LXR involving Delta9-desaturation, and chain elongation followed by esterification leads to detoxification of saturated FA and prevents beta cell death.
###end p 60
###begin title 61
Methods
###end title 61
###begin title 62
Materials
###end title 62
###begin p 63
###xml 225 227 225 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
Chemicals and FA were purchased from Sigma-Aldrich (Bornem, Belgium). Stock solutions of FA were prepared in 90% ethanol. Stock solutions of clofibrate, TO1317, PCN and 9-cis RA were dissolved in absolute ethanol or DMSO. [U-14C]-palmitic acid was obtained from Perkin Elmer Life Sciences (Zaventem, Belgium).
###end p 63
###begin title 64
Ethics statement
###end title 64
###begin p 65
###xml 235 240 <span type="species:ncbi:9606">Human</span>
###xml 305 310 <span type="species:ncbi:9606">Human</span>
Animal experiments were approved by the local Ethical Committee for Animal Experimentation of the Vrije Universiteit Brussel. All manipulations were carried out in accordance with the European Community Council Directive (86/609/EEC). Human endocrine cells were obtained from the Brussels-Beta Cell Bank. Human pancreata from donors at European hospitals affiliated with Eurotransplant Foundation (Leiden, The Netherlands) are processed by the Beta-Cell Bank of the Juvenile Diabetes Research Foundation Center for Beta Cell Therapy in Brussels with the purpose of preparing islet cell grafts for clinical trials. Isolated fractions that do not fulfill the quality criteria for transplantation, can be made available to research projects approved by the Medical Ethics Committee of the University Hospital (UZ Brussel-Vrije Universiteit Brussel). Approval to use beta cells for this project was obtained from the Medical Ethics Committee of the UZ Brussels - Vrije Universiteit Brussel.
###end p 65
###begin title 66
Isolation and culture of beta cell preparations
###end title 66
###begin p 67
###xml 150 153 142 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 162 165 151 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 188 191 166 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 281 285 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Steffensen1">[71]</xref>
###xml 724 728 702 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Pipeleers1">[72]</xref>
###xml 1046 1049 1024 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Martens1">[8]</xref>
###xml 1051 1055 1029 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Kiekens1">[10]</xref>
###xml 1057 1061 1035 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Heimberg1">[37]</xref>
###xml 1180 1184 1158 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Ling2">[73]</xref>
###xml 71 75 <span type="species:ncbi:10116">rats</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 287 290 <span type="species:ncbi:10116">Rat</span>
###xml 295 300 <span type="species:ncbi:10090">mouse</span>
###xml 757 760 <span type="species:ncbi:10116">rat</span>
###xml 1063 1068 <span type="species:ncbi:9606">Human</span>
###xml 1161 1165 <span type="species:ncbi:163112">Ling</span>
Pancreatic islets were isolated from 10 wks old male Wistar and Zucker rats (lean and fa/fa) and male LXR knock-out mice (8 to 12 wks),. LXRalphaalpha-/-, LXRbeta-/-, and LXRalphaalphabeta-/- mice were backcrossed from a 129/Sv to a C57BL/6 background for at least ten generations [71]. Rat and mouse islets were dissociated into single cells and purified by FACS into beta cells (mean purity 90% insulin-positive cells) and alpha enriched-cells (75% glucagon-positive cells, 25% insulin-positive cells) using cellular light-scatter and FAD-autofluorescence as discriminating parameters. The methods for rodent islet isolation, dissociation and FACS purification of islet beta and alpha cells have been described previously [72]. In one set of experiments, rat beta cell subpopulations with, respectively, high and low glucose-responsiveness were FACS sorted using glucose-induced increases in cellular level of NAD(P)H-autofluorescence as discriminator, as described in our previous studies reporting on the identity and function of these cells [8], [10], [37]. Human endocrine cells were obtained from the Brussels-Beta Cell Bank and prepared as described by Ling and Pipeleers [73]. These endocrine fractions were enriched by FACS to a mean purity of 60% beta cells and further enriched under culture conditions favoring beta cell survival.
###end p 67
###begin p 68
###xml 735 739 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Richieri1">[74]</xref>
For cell viability experiments, beta cells were cultured in polylysin-coated microtiter plates with Ham's F10 containing 10 mM glucose, 1% charcoal-extracted BSA (fraction V, radioimmunoassay grade, Boerhinger-Mannheim), 2 mM L-glutamine, 50 mM 3-isobutyl-1-methyl-xanthine, 0.075 mg/ml penicillin and 0.1 mg/ml streptomycin. Test reagents were added, with controls receiving similar dilutions of solvent. The unbound FFA concentrations in the presence of 1% albumin were calculated to correspond to 9 and 27 nM after addition of 250 and 500 microM palmitate using a multiple stepwise equilibrium model using the association constants for binding of palmitate to the first six binding sites of albumin, as described by Richieri et al. [74].
###end p 68
###begin p 69
###xml 145 148 145 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Cnop2">[6]</xref>
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Pipeleers1">[72]</xref>
Media were refreshed every 2 to 3 days. The percent living and dead cells was determined as previously described and toxicity indices calculated [6]. For metabolic and gene expression studies, freshly isolated cells were re-aggregated and cultured in suspension [72].
###end p 69
###begin p 70
Samples for electron microscopy were fixed in cacodylate-buffered glutaraldehyde (4.5%, pH 7.3), postfixed in osmium tetroxide (1%) and embedded in Spurr's resin. Ultrathin sections were stained with uranylacetate and lead citrate and examined on a Zeiss EM 109 electron microscope. Nile red (Molecular probes, Invitrogen) was used to detect lipid accumulation in living cells (axioplan, Zeiss).
###end p 70
###begin p 71
###xml 76 78 76 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 111 113 107 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 190 193 182 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Hellemans1">[7]</xref>
###xml 210 212 202 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 273 275 265 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 277 278 269 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 278 282 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Schuit1">[75]</xref>
Palmitate oxidation was measured in KRBH medium containing 0.2% BSA, 2 mM Ca2+, 10 mM hepes and 0.5 microCi [U-14C]-palmitic acid, and 250 microM unlabeled palmitic acid, as described prior [7]. The rate of [U-14C]-palmitic acid oxidation was assessed through formation of 14CO2[75].
###end p 71
###begin title 72
LXR Agonist Treatment
###end title 72
###begin p 73
###xml 5 16 <span type="species:ncbi:10116">Wistar rats</span>
###xml 223 227 <span type="species:ncbi:10116">rats</span>
Male Wistar rats (approx. 250 g), were treated with 40 mg/kg body weight/day of LXR agonist TO1317 (Sigma-Aldrich) dissolved in DMSO/PBS (1:3), given daily at the onset of the dark cycle by oral gavages for 5 days. Control rats were given only vehicle. After 5 days beta cells and alpha-enriched cells were FACS-purified and used for viability assays as described.
###end p 73
###begin title 74
siRNA Transfection
###end title 74
###begin p 75
###xml 186 190 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-Martens2">[76]</xref>
###xml 47 50 <span type="species:ncbi:10116">rat</span>
###xml 204 207 <span type="species:ncbi:10116">rat</span>
Transfection was conducted in freshly isolated rat beta cells. Cells were aggregated in presence of 50 nM siRNA-lipid complexes using Jetsi-ENDO (Polyplus, France) as transfection agent [76]. siRNA's for rat SCD1 and SCD2 were siGENOME SMART pool reagents (J-096598-00 and L-099222-01; Dharmacon), pools of four different siRNAs. Control cells were treated with Jetsi-ENDO only or transfected with non-targeting siGLO RISC-free (D-001600-01). Transfection did not result in cytotoxicity. After 24 h, aggregates were dissociated to single cells. Half of the cells were used in the toxicity assay with an additional 72 h culture; the other half was reaggregated and RNA extracted 24 h later. Over 95% of reaggregated siGLO-transfected beta cells showed cytoplasmic siRNA-associated fluorescence.
###end p 75
###begin title 76
Gene, protein and lipid analysis of beta cell aggregates
###end title 76
###begin p 77
RNA was extracted using RNeasy columns (Qiagen). RNA quality was verified by Agilent Bioanalyzer. Following removal of genomic DNA (TURBO DNA-free, Ambion, Austin, Texas, U.S.A.) and reverse-transcription (High-Capacity cDNA Archive Kit, Applied Biosystems, Foster City, U.S.A.), targets were amplified on ABI Prism 7700 using TaqMan Universal PCR Master Mix and specific TaqMan MGB probes (Applied Biosystems, assays' IDs available on request). Expression levels of target genes were normalized to beta-actin or 18S (DeltaCt) and expressed versus a chosen calibrator (comparative DeltaDeltaCt method).
###end p 77
###begin p 78
###xml 287 292 <span type="species:ncbi:10090">mouse</span>
###xml 399 410 <span type="species:ncbi:3704">Horseradish</span>
Beta cell aggregates were lysed in RIPA buffer containing protease inhibitors (Sigma). Proteins were resolved by SDS-PAGE on 10% (w/v) acrylamide:bisacrylamide gels and transferred to nitrocellulose membranes using iblot (Invitrogen, Belgium). Immunodetection of SCD was performed using mouse anti-SCD1/2 antibodies (Abcam). Hsp70 served as housekeeping control (Santa Cruz Biotechnology, CA, USA). Horseradish peroxidase-linked secondary antibodies (Santa Cruz Biotechnology) were used. Immunoreactive proteins were visualized by enhanced chemiluminescence (ECL, Pierce).
###end p 78
###begin p 79
###xml 186 190 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007266-VanVeldhoven1">[77]</xref>
###xml 851 852 841 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Lipid extracts were prepared from beta cell aggregates, fortified with 10 nmol tricosanoic acid (IS), dried and treated with 0.5 ml 0.5 N HCl in 90% acetonitrile at 100degreesC for 1 hr [77]. After adding water, released FA were extracted in 2x1 ml hexane, and an aliquot of the aqueous phase was analyzed for phosphate to estimate phospholipid content. The hexane extract was dried, silylated with N-tert butyldimethylsilyl-N-methyltrifluoroacetamide with 1% tert butyldimethylchlorosilane (Pierce)/pyridine (1/1, v/v) and analyzed by GC-MS (Trace GC-MS, Thermo Finnigan), equipped with an automated cold-on-column injector and high oven temperature device connected to a BPX70 column (30mx0.25 mm; 0.25 microm). Fatty acids were identified by comparing elution times to standards and by their mass spectrum. Total ion current signals, obtained in EI+ mode at 35 eV, were related to the IS signal and converted to nmol fatty acid using relative response factors by analyzing a reference fatty acid mixture containing tricosanoic acid (GLC-538, free acids; Nu-Chek Prep), derivatized like the extracts.
###end p 79
###begin title 80
Data analysis
###end title 80
###begin p 81
###xml 121 122 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 241 242 239 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 272 273 270 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Data are presented as means+/-SD of n independent experiments. Single comparisons were performed by the Student's paired t-test. For multiple comparisons, data were analyzed by ANOVA, and group comparisons using Student's paired or unpaired t test, with correction of the P values for multiple comparisons by the Bonferroni method.
###end p 81
###begin title 82
Supporting Information
###end title 82
###begin p 83
Effect of inhibition of SCD on GC-MS fatty acid profiles. Beta cells were exposed for 8 days to 250 microM-P+/-1 microM TO1317+/-t10,c12 CLA (40 microM). Lipid extracts were prepared and analyzed by GC-MS as described. a) Representative chromatograms, covering the elution of C14:0 till C22:6 Figure representative for 6 independent analyses. b) The ratios between the saturated and monounsaturated FA were calculated. Mean+/-SE, n = 5 - 6, * p<0.05, ** p<0.01 versus control, $ p<0.05, $$<P 0.01 versus palmitate
###end p 83
###begin p 84
(1.47 MB TIF)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
Effect of TO1317 on cytotoxicity of FA with different chain length and saturation. Beta cells were exposed for 2 or 8 days to the indicated FA+/-1 microM TO1317. Mean+/-SD (n>4), # P<0.001 toxicity of different FA compared to C16:0; * P<0.05, *** P<0.001, the TO1317 condition compared to the respective control FA condition.
###end p 86
###begin p 87
(0.04 MB DOC)
###end p 87
###begin p 88
Click here for additional data file.
###end p 88
###begin p 89
###xml 45 49 <span type="species:ncbi:10090">mice</span>
mRNA expression levels in islets from LXR KO mice relative to wild type. qPCR values normalized against 18S and compared relative to the expression levels in wild type islets. Unpaired student t-test, two tailed, mean+/-SD, n = 3, Differences were considered significant with p<0.01. ** p<0.01 and *** p<0.001, compared to wild type control. ND = not detected
###end p 89
###begin p 90
(0.05 MB DOC)
###end p 90
###begin p 91
Click here for additional data file.
###end p 91
###begin p 92
###xml 55 59 <span type="species:ncbi:10116">rats</span>
mRNA expression levels in beta cells from Zucker obese rats relative to lean controls. qPCR values normalized against beta-actin and expressed relative to the expression levels in beta cells from Zucker lean controls. Unpaired student t-test, two tailed, mean+/-SD, n = 3, Differences were considered significant with ** p<0.01 and *** p<0.001.
###end p 92
###begin p 93
(0.05 MB DOC)
###end p 93
###begin p 94
Click here for additional data file.
###end p 94
###begin p 95
The authors thank the cell preparation team at the Diabetes Research Center and at the Beta Cell Bank for providing the preparations used in this study. They acknowledge the expert technical assistance of K. Suenens, L. Heylen and G. Stange. Electron microscopy was performed by M. Berghmans at the Unit of Experimental pathology at the Vrije Universiteit Brussel.
###end p 95
###begin title 96
References
###end title 96
###begin article-title 97
Mechanisms of beta-cell death in type 2 diabetes.
###end article-title 97
###begin article-title 98
Failure of beta-cell adaptation in type 2 diabetes: Lessons from animal models.
###end article-title 98
###begin article-title 99
Glucolipotoxicity: fuel excess and beta-cell dysfunction.
###end article-title 99
###begin article-title 100
Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes.
###end article-title 100
###begin article-title 101
Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes.
###end article-title 101
###begin article-title 102
Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation.
###end article-title 102
###begin article-title 103
Peroxisome proliferator-activated receptor alpha-retinoid X receptor agonists induce beta-cell protection against palmitate toxicity.
###end article-title 103
###begin article-title 104
Glucose suppresses superoxide generation in metabolically responsive pancreatic beta cells.
###end article-title 104
###begin article-title 105
###xml 29 32 <span type="species:ncbi:10116">rat</span>
Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program.
###end article-title 105
###begin article-title 106
###xml 49 52 <span type="species:ncbi:10116">rat</span>
Differences in glucose recognition by individual rat pancreatic B cells are associated with intercellular differences in glucose-induced biosynthetic activity.
###end article-title 106
###begin article-title 107
Perilipin is present in islets of Langerhans and protects against lipotoxicity when overexpressed in the beta-cell line INS-1.
###end article-title 107
###begin article-title 108
###xml 93 98 <span type="species:ncbi:9606">human</span>
Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function.
###end article-title 108
###begin article-title 109
Different role of saturated and unsaturated fatty acids in beta-cell apoptosis.
###end article-title 109
###begin article-title 110
Differential regulation of the ER stress response by long-chain fatty acids in the pancreatic beta-cell.
###end article-title 110
###begin article-title 111
Glucolipotoxicity in INS-1E cells is counteracted by carnitine palmitoyltransferase 1 over-expression.
###end article-title 111
###begin article-title 112
Fatty acids rapidly induce the carnitine palmitoyltransferase I gene in the pancreatic beta-cell line INS-1.
###end article-title 112
###begin article-title 113
Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism.
###end article-title 113
###begin article-title 114
Triglyceride accumulation protects against fatty acid-induced lipotoxicity.
###end article-title 114
###begin article-title 115
Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro.
###end article-title 115
###begin article-title 116
Increased fatty acid desaturation and enhanced expression of stearoyl coenzyme A desaturase protects pancreatic beta-cells from lipoapoptosis.
###end article-title 116
###begin article-title 117
###xml 46 51 <span type="species:ncbi:9606">human</span>
Induction of stearoyl-CoA desaturase protects human arterial endothelial cells against lipotoxicity.
###end article-title 117
###begin article-title 118
Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation.
###end article-title 118
###begin article-title 119
LXRS and FXR: the yin and yang of cholesterol and fat metabolism.
###end article-title 119
###begin article-title 120
Sweet dreams for LXR.
###end article-title 120
###begin article-title 121
LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function.
###end article-title 121
###begin article-title 122
Sterol regulatory element-binding protein 1 mediates liver X receptor-beta-induced increases in insulin secretion and insulin messenger ribonucleic acid levels.
###end article-title 122
###begin article-title 123
Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis.
###end article-title 123
###begin article-title 124
Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro.
###end article-title 124
###begin article-title 125
Elevated insulin secretion from liver x receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.
###end article-title 125
###begin article-title 126
An update on lipotoxic endoplasmic reticulum stress in pancreatic beta-cells.
###end article-title 126
###begin article-title 127
Loss of Ncb5or results in impaired fatty acid desaturation, lipoatrophy, and diabetes.
###end article-title 127
###begin article-title 128
The flavoheme reductase Ncb5or protects cells against er stress induced lipotoxicity.
###end article-title 128
###begin article-title 129
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta.
###end article-title 129
###begin article-title 130
Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c.
###end article-title 130
###begin article-title 131
###xml 150 154 <span type="species:ncbi:10116">rats</span>
Effect of dietary lipids and endocrine changes on polyunsaturated fatty acids in phospholipids of pancreas and brown adipose tissue of obese and lean rats.
###end article-title 131
###begin article-title 132
Glibenclamide treatment recruits beta-cell subpopulation into elevated and sustained basal insulin synthetic activity.
###end article-title 132
###begin article-title 133
Heterogeneity in glucose sensitivity among pancreatic beta-cells is correlated to differences in glucose phosphorylation rather than glucose transport.
###end article-title 133
###begin article-title 134
###xml 91 99 <span type="species:ncbi:9606">patients</span>
Long-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetes.
###end article-title 134
###begin article-title 135
###xml 49 53 <span type="species:ncbi:10116">rats</span>
Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.
###end article-title 135
###begin article-title 136
Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells.
###end article-title 136
###begin article-title 137
Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue.
###end article-title 137
###begin article-title 138
Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis.
###end article-title 138
###begin article-title 139
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse Elovl-6 promoter is an SREBP target.
###end article-title 139
###begin article-title 140
SREBPs: Physiology and pathophysiology of the SREBP family.
###end article-title 140
###begin article-title 141
Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic beta-cells.
###end article-title 141
###begin article-title 142
The cytoprotective actions of long-chain mono-unsaturated fatty acids in pancreatic beta-cells.
###end article-title 142
###begin article-title 143
Nuclear receptors and the control of metabolism.
###end article-title 143
###begin article-title 144
###xml 111 115 <span type="species:ncbi:10090">Mice</span>
###xml 144 149 <span type="species:ncbi:9606">Human</span>
Peroxisome Proliferator-Activated Receptor alpha Improves Pancreatic Adaptation to Insulin Resistance in Obese Mice and Reduces Lipotoxicity in Human Islets.
###end article-title 144
###begin article-title 145
Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c.
###end article-title 145
###begin article-title 146
SREBP1 is required for the induction by glucose of pancreatic beta-cell genes involved in glucose sensing.
###end article-title 146
###begin article-title 147
###xml 77 80 <span type="species:ncbi:10116">rat</span>
Over-expression of sterol-regulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR).
###end article-title 147
###begin article-title 148
ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity.
###end article-title 148
###begin article-title 149
Sterol regulatory element-binding protein-1c and pancreatic beta-cell dysfunction.
###end article-title 149
###begin article-title 150
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Granuphilin is activated by SREBP-1c and involved in impaired insulin secretion in diabetic mice.
###end article-title 150
###begin article-title 151
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
Transgenic mice overexpressing nuclear SREBP-1c in pancreatic beta-cells.
###end article-title 151
###begin article-title 152
Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic islets.
###end article-title 152
###begin article-title 153
###xml 100 103 <span type="species:ncbi:10116">rat</span>
Limited role for SREBP-1c in defective glucose-induced insulin secretion from Zucker diabetic fatty rat islets: a functional and gene profiling analysis.
###end article-title 153
###begin article-title 154
Activation of liver X receptors and retinoid X receptors induces growth arrest and apoptosis in insulin-secreting cells.
###end article-title 154
###begin article-title 155
Activation of liver X receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrest.
###end article-title 155
###begin article-title 156
Hepatic peroxisomal fatty acid beta-oxidation is regulated by liver X receptor alpha.
###end article-title 156
###begin article-title 157
Differential activation of ER stress and apoptosis in response to chronically elevated free fatty acids in pancreatic beta-cells.
###end article-title 157
###begin article-title 158
Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
###end article-title 158
###begin article-title 159
Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation.
###end article-title 159
###begin article-title 160
Effects of leptin, troglitazone, and dietary fat on stearoyl CoA desaturase.
###end article-title 160
###begin article-title 161
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice.
###end article-title 161
###begin article-title 162
Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome.
###end article-title 162
###begin article-title 163
Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance.
###end article-title 163
###begin article-title 164
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.
###end article-title 164
###begin article-title 165
###xml 93 101 <span type="species:ncbi:9606">patients</span>
Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus.
###end article-title 165
###begin article-title 166
###xml 99 102 <span type="species:ncbi:9606">men</span>
Long-term predictors of insulin resistance: role of lifestyle and metabolic factors in middle-aged men.
###end article-title 166
###begin article-title 167
Gene expression profiling in adipose tissue indicates different transcriptional mechanisms of liver X receptors alpha and beta, respectively.
###end article-title 167
###begin article-title 168
A new in vitro model for the study of pancreatic A and B cells.
###end article-title 168
###begin article-title 169
###xml 22 27 <span type="species:ncbi:9606">human</span>
Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation.
###end article-title 169
###begin article-title 170
Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB.
###end article-title 170
###begin article-title 171
Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells.
###end article-title 171
###begin article-title 172
Specificity in beta cell expression of L-3-hydroxyacyl-coA dehydrogenase, short-chain (HADHSC) and potential role in down-regulating insulin release.
###end article-title 172
###begin article-title 173
###xml 102 107 <span type="species:ncbi:9606">human</span>
Effect of harvesting methods, growth conditions and growth phase on diacylglycerol levels in cultured human adherent cells.
###end article-title 173
###begin p 174
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: JAG is shareholder, research grant receiver and consultant of KaroBio AB. The funders did not play a role in this particular study. The Diabetes Research Center is a partner of the Juvenile Diabetes Research Center for Beta Cell Therapy in Diabetes. The other authors have no financial conflict of interest to disclose.
###end p 174
###begin p 175
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the Research Foundation Flanders to KH (FWO-1.5.195.05, FWO-1.5.193.08), the Interuniversity Attraction Poles phase VI (IAP P6/40 - DP coordinator) from the Belgian Science Policy, from the 6th EU-framework (#512145-DP coordinator), from the geconcentreerde onderzoeksacties van de Vlaamse Gemeenschap (GOA 2004/08 to PPVV), the Norwegian Research Council (KRS), the Swedish Research Council (JAG) and a general nuclear receptor research grant from karobio Ab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 175

